Steven H. Collis

Steven H. Collis is a declared insider at 3 companies (chief executive); the most frequent names are Cencora, Inc., Bausch & Lomb Corp and Elevance Health, Inc. The record holds 73 filings, for trades running from 11 May 2021 to 26 May 2026.

The open-market side counts 2 purchases for €973k alongside 6 sales for €25.2M. Taken together, the sales exceed the purchases by €24.3M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 9 share grants and 53 option exercises. Since January 2026: 2 purchases and no sales on the market.

The record was last updated on 28 May 2026 with a share grant (€215k) in Bausch & Lomb Corp. The last insider purchase was made public on 6 March 2026, 226 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.